iBio (IBIO) Current Assets (2011 - 2026)

iBio (IBIO) has 16 years of Current Assets data on file, last reported at $77.3 million in Q1 2026.

• On a quarterly basis, Current Assets rose 1174.77% year-over-year to $77.3 million in Q1 2026; TTM through Mar 2026 was $77.3 million, a 1174.77% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, down 37.97% from the prior year.
• Current Assets for Q1 2026 stood at $77.3 million, up from $53.4 million in the prior quarter.
• Over the last five years, Current Assets for IBIO reached as high as $77.3 million in Q1 2026 and fell as low as $6.1 million in Q1 2025.
• Historically, Current Assets has averaged $33.7 million across 5 years, with a median of $27.1 million in 2023.
• Across the five-year window, Current Assets slumped 83.23% in 2025 and jumped 1174.77% in 2026, its largest moves.
• Year by year, Current Assets stood at $38.2 million in 2022, then tumbled by 48.48% to $19.7 million in 2023, then tumbled by 57.94% to $8.3 million in 2024, then soared by 544.54% to $53.4 million in 2025, then jumped by 44.66% to $77.3 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $77.3 million in Q1 2026, $53.4 million in Q4 2025, and $50.8 million in Q3 2025.